If you are looking for a comprehensive clinical review and don’t want to spend too much time away from the office, attend the Three-day Clinical Review. The Three-day Clinical Review includes the GI Pathology and Imaging Course and What’s New in GI Pharmacology Course, plus the popular Postgraduate Course. Leading experts in the subspecialties will delve deeper into topics of interest to you and address the common and not-so-common GI disorders you encounter in practice.
Friday, October 5, 2018 (Day 1- Morning)
GI Pathology and Imaging Course
ACG’s Pathology and Imaging in the Evaluation of Gastrointestinal Disease Course includes four mini-sessions, each devoted to new developments and old problems of special interest to the clinical gastroenterologist in pathology and imaging in a specific portion of the GI tract. A popular biennial offering of the College, this year’s course expands the mini-session concept to include a combination lecture by a pathologist and a radiologist with the addition of correlated endoscopic images. Presentations will focus on:
- Current concepts relevant to radiology and pathology in the evaluation and treatment of patients with gastrointestinal disease.
- Findings of radiologic exams related to gastrointestinal disorders of the esophagus, stomach, small bowel, large intestine, liver, gallbladder, and pancreas.
- Basic and advanced pathology findings in patients with gastrointestinal illnesses through close examination of representative photomicrographs.
- Typical radiology and pathology findings with endoscopic images reflective of both the normal and abnormal physiology and pathophysiology.
Friday, October 5, 2018 (Day 1 – Afternoon)
What’s New in GI Pharmacology Course
Attend What’s New in GI Pharmacology Course for an intensive review of key GI pharmacology, including comparisons and contrasts between conventional and emerging pharmacological treatment options. This three-hour course will consist of lectures and Q & A sessions on such topics as:
- Epidemiology, diagnostic processes, and best practices for the management of functional dyspepsia.
- Questions and concerns regarding use of PPIs in a variety of clinical scenarios and current evidence regarding short- and long-term safety of PPIs.
- Various presentations of symptomatic diverticular disease along with current therapeutic approaches.
- Evidence for and against the application of antibiotic prophylaxis in patients with gastroenterological diseases or undergoing endoscopic procedures.
- Current and emerging pharmacologic treatment options for constipation, including chronic idiopathic constipation, opioid-induced constipation, and IBS-C.
- Issues and interventions currently available for the management of patients with fatty liver disease, with a focus on available pharmacologic approaches.
- Evidence for and against chemoprevention for malignancies of the gastrointestinal tract and provide recommendations for appropriate use.
- Use of therapeutic drug monitoring in IBD patients and how to optimize immunosuppressive drug therapy with regard to adjusting therapy in class or switching classes of biologics..
Saturday, October 6 – Sunday, October 7, 2018 (Days 2 and 3 – All Day)
With the need to remain abreast of the many new and emerging advancements in the field of gastroenterology and the volume of patients continuing to increase as the population ages, the clinical gastroenterologist is more challenged than ever to deliver the best patient care in each situation they encounter. Research in a multitude of gastroenterology and hepatology areas progresses at a rapid pace. Advances in technology, diagnostic modalities, and therapeutic options have had a positive impact on the management of many GI diseases. Scientific education, based on critical foundational knowledge and clinical skills, the communication of practical methods for treatment, and the ability to integrate the newest tools in diagnosis with the latest therapeutic/treatment options, are key necessities for the GI clinician to deliver top-quality patient care.
- IBS—pharmacologic and non-pharmacologic treatments
- Food allergies, sensitivities and specialty diets
- Chronic abdominal pain and bloating
- Translational approaches to common GI diseases
- Drug-Induced Liver Injury
- Liver masses
- Viral Hepatitis
- Managing the pregnant patient
- Variceal, non-variceal, and obscure GI bleeding
- C. difficile
- H. pylori
- Acute and chronic pancreatitis
- Cystic neoplasms of the pancreas
- PLUS 12 optional learning luncheons
- Biologic and non-biologic therapies of IBD
- Quality in IBD care
- Endoscopy in IBD
- Colorectal cancer prevention
- Personalized CRC screening and surveillance
- Managing patients with increased CRC risk
- Optimal colonoscopy technique and polypectomy
- Colonoscopy quality
- Sedation for endoscopy
- Prevention of post-procedure bleeding
- Taking care of the endoscopist
- Preventive care of the cirrhotic patient
- Alcoholic liver disease
- Liver transplantation
- Chronic constipation
- Delayed gastric emptying
- Esophageal motility disorders other than achalasia
- Evidence-based PPI use
- Pre-malignant lesions of the esophagus
- Pre-malignant lesions and polyps of the stomach
- PLUS 12 optional learning luncheons